Renal Dose Adjustment

The core biometric module that computes the estimated glomerular filtration rate (eGFR) using serum creatinine, age, sex, and race-neutral equations like CKD-EPI 2021. This value serves as the primary input for all downstream dosing logic.

• Ingests structured lab data from HL7 ORU messages
• Supports multiple equations: Cockcroft-Gault, MDRD, CKD-EPI
• Dynamically selects the appropriate formula based on clinical context (e.g., drug-specific FDA labeling requirements)
• Handles edge cases like amputations, pregnancy, and unstable renal function

A curated, machine-readable repository of renal dosing guidelines derived from FDA Structured Product Labeling (SPL) and tertiary references like Lexicomp. Each monograph maps specific eGFR thresholds to discrete dose adjustments.

• Encodes rules as structured JSON: { "drug": "Levofloxacin", "threshold": 50, "action": "reduce_dose_50pct" }
• Distinguishes between dose reduction and interval extension recommendations
• Flags absolute contraindications below critical clearance thresholds
• Maintains version control and audit trails for all monograph updates

The synchronous decision service that intercepts Computerized Physician Order Entry (CPOE) messages and evaluates the ordered medication against the patient's current eGFR before the order is finalized.

• Operates within sub-second latency to avoid workflow disruption
• Generates HL7 ORU alert messages with actionable dose recommendations
• Suppresses duplicate alerts for the same drug-eGFR combination within a configurable time window
• Routes critical alerts to pharmacy for concurrent verification

A deterministic rules engine that identifies medications with absolute contraindications in renal impairment, not merely dose adjustments. These drugs must be discontinued or avoided entirely.

• Flags nephrotoxic agents (e.g., NSAIDs, aminoglycosides) in patients with acute kidney injury
• Screens for metformin in patients with eGFR < 30 mL/min per FDA boxed warnings
• Identifies direct oral anticoagulants (DOACs) requiring renal status assessment before initiation
• Integrates with allergy and drug-drug interaction modules for holistic safety screening

An advanced module that applies population pharmacokinetic (PopPK) models to simulate drug exposure over time, moving beyond static eGFR thresholds to predict area under the curve (AUC) and trough concentrations.

• Utilizes Bayesian forecasting for vancomycin and aminoglycoside dosing
• Incorporates patient covariates: weight, fluid status, and concomitant nephrotoxins
• Generates model-informed precision dosing (MIPD) recommendations
• Outputs predicted concentration-time curves for clinician review

A retrospective analytics module that tracks every renal dose adjustment alert, override, and outcome to support pharmacy quality improvement and regulatory compliance.

• Calculates override rates stratified by drug class and clinician specialty
• Identifies patterns of alert fatigue requiring threshold tuning
• Generates reports for Pharmacy & Therapeutics (P&T) committee review
• Supports Joint Commission medication management standards (MM.04.01.01)

The primary biometric input for renal dose adjustment, calculated from serum creatinine, age, sex, and race. The CKD-EPI and Cockcroft-Gault equations are the standard algorithms used to estimate kidney function.

• Staging: Maps eGFR values to CKD stages (G1-G5) to determine severity.
• BSA Normalization: eGFR is often normalized to a standard body surface area of 1.73 m², which may require de-indexing for obese patients.
• Drug-Specific Thresholds: Monographs typically define cutoffs like eGFR < 30 mL/min for contraindication.

The structured knowledge base containing the rules that govern how a medication's dosage must change relative to renal function. This logic is ingested from Structured Product Labeling (SPL) documents.

• Dosage Bands: Define specific reduced doses for eGFR ranges (e.g., 50% dose for eGFR 30-50).
• Interval Extension: Instead of reducing the dose, the logic may extend the dosing interval (e.g., from Q8H to Q12H).
• Absolute Contraindication: Flags drugs like nitrofurantoin that are strictly prohibited below a certain eGFR threshold.

A computational flag that identifies medications with known potential to cause further kidney injury, requiring heightened surveillance beyond simple dose adjustment.

• Direct Tubular Toxicity: Agents like aminoglycosides and IV contrast dye.
• Crystal Nephropathy: Drugs like acyclovir that can precipitate in renal tubules.
• Hemodynamic Effects: NSAIDs that reduce glomerular perfusion pressure.
• The system cross-references the active medication list to calculate a cumulative nephrotoxic burden score.

The clinical process of measuring specific drug levels in the blood to guide dosing, often triggered when the renal adjustment logic flags a narrow therapeutic index drug.

• Narrow Therapeutic Index: Drugs like vancomycin and gentamicin require TDM because the gap between efficacy and toxicity is small.
• Trough Levels: The system may recommend a trough draw immediately before the next dose to ensure clearance is adequate.
• AUC-guided Dosing: Advanced logic uses area-under-the-curve calculations rather than simple troughs for vancomycin monitoring.

The deterministic and probabilistic logic systems that verify the accuracy and completeness of the AI-generated renal dose recommendation before it reaches the clinician.

• Unit Conversion Checks: Validates that mg/kg calculations have been performed correctly.
• Temporal Consistency: Ensures the eGFR value used is current (within 24-48 hours) and not a historical lab value.
• Drug-Disease Interaction: Cross-references the renal adjustment against other active conditions, such as dialysis status or acute kidney injury flags.

The desensitization of clinicians to safety warnings caused by excessive exposure to irrelevant or false-positive renal dose alerts. The logic engine must be tuned to suppress non-actionable noise.

• Tiered Severity: Classifying alerts as 'Hard Stop' (contraindication) vs. 'Advisory' (minor adjustment) to reduce cognitive load.
• Contextual Suppression: Silencing a renal alert if the patient is on dialysis and the drug is dialyzable.
• Override Analytics: Tracking which alerts are consistently overridden to refine the sensitivity of the rules engine.